StageZero Life Sciences Announces Q2 2021 Financial Results and Operational Update
Company Signs Definitive Agreement to Acquire Health Clinics LimitedTORONTO, ON / ACCESSWIRE / August 17, 2021 / StageZero Life Sciences...
Month: August 2021
Better Choice Company Board of Directors Authorize Stock Repurchase Program
NEW YORK, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE American: BTTR) (“Better Choice” or “the Company”),...
Aidin Introduces Prior Authorization Solution to Accelerate and Streamline Discharge Planning
Integration — and Automation — of Referral and Prior Authorization Workflows Improves Care TransitionsNEW YORK, Aug. 17, 2021 (GLOBE NEWSWIRE)...
AIM ImmunoTech Provides Second Quarter 2021 Business Update
A visual of Ampligen as an intranasal therapy A visual of Ampligen as an intranasal therapy OCALA, Fla., Aug. 17,...
Cannabix Technologies Granted U.S. Patent for FAIMS molecular analysis device
Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER, British Columbia,...
Neuronetics Launches New Website to Meet Patient Demand for Depression Resources
New site enhances the user experience and offers expanded content for depression sufferersMALVERN, Pa., Aug. 17, 2021 (GLOBE NEWSWIRE) --...
Imagin Medical on Schedule for American Urology Association Demonstration
VANCOUVER, British Columbia, and BOSTON, Aug. 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB:...
Medicare Data: Significant Reductions in Amputations, Emergency Visits, and Hospital Readmissions Associated with Advanced Treatment Using Skin Substitute Products for Lower Extremity Diabetic Ulcers (LEDUs)
New study shows advanced treatment (AT) for management of LEDUs among Medicare beneficiaries is associated with significant reductions in major...
USA Equities Corp. Announces Strong Second Quarter 2021 Results
Second Quarter 2021 Financial Results In-Line with July Pre-AnnouncementSuccessful $750,000 Capital Raise Increases Financial Flexibility to Execute on Growth StrategyAcquired...
Orchestra BioMed™ Announces Peer-Reviewed Publication of MODERATO II Study Results Showing a Statistically Significant Reduction in Blood Pressure in Pacemaker-Indicated Patients Treated with BackBeat Cardiac Neuromodulation Therapy™
Double-blind, randomized trial data show a clinically meaningful and statistically significant net reduction of 8.1 mmHg in 24-hour ambulatory systolic...
Study Finds 65% of Workers Would Give Up Bonuses, Vacation, and Flexible Hours for Better Healthcare Benefits
SAN FRANCISCO, Aug. 17, 2021 (GLOBE NEWSWIRE) -- A new study by One Medical (NASDAQ: ONEM), a leading national member-based...
CytomX Therapeutics Announces New Employment Inducement Grants
SOUTH SAN FRANCISCO, Calif., Aug. 17, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage, oncology-focused biopharmaceutical company pioneering...
Candel Therapeutics Announces Closing of Initial Public Offering, Including the Partial Exercise of Underwriters’ Option
NEEDHAM, Mass., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (“Candel”), a late clinical stage biopharmaceutical company developing novel...
Reflect Scientific Inc. Releases Second Quarter 2021 Financials
OREM, Utah, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services...
Senti Bio Adds Prominent Scientific and Industry Leaders to its Scientific Advisory Board
- Members include world-leading experts in fields of immunotherapy drug discovery and development and commercial oncology therapeutics - - Dr....
BioSyent Schedules Q2 and H1 2021 Earnings Release for August 25, 2021
MISSISSAUGA, Ontario, Aug. 17, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its...
Cidara Therapeutics and Mundipharma Announce Completion of Enrollment in the Phase 3 ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis
Top-line data anticipated in late 2021 Single Phase 3 trial serves as basis for global regulatory filings SAN DIEGO and CAMBRIDGE,...
PolyPid to Present at First World Association Against Infection in Orthopaedics and Trauma Congress
Virtual Presentation to be led by PolyPid Co-Founder and CSO on August 28, 2021PETACH TIKVA, Israel, Aug. 17, 2021 (GLOBE NEWSWIRE)...
Qualigen Therapeutics, Inc. Provides Update on Product Development Priorities and Reports Second Quarter and Six Month 2021 Financial Results
CARLSBAD, Calif.,, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN) today announces its intention to prioritize its...
Zenith Epigenetics Announces a Publication in the Journal of Cancer Gene Therapy with Compelling Data for the Treatment of ER-Positive Breast Cancer Patients
ZEN-3694 has therapeutic potential in combination with CDK4/6 inhibitors in patients with advanced ER+ breast cancer resistant to CDK4/6 inhibitorsCALGARY,...